GlassScriptPhysician profile
Solomon A David
NPI 1457424541
$18,091.57
in general payments reported to CMS, 2019-2025
18 companies · $740 in 2025
The $740 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $279 · 2022: $1,449 · 2023: $11K · 2024: $4,058 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $4,983 · Food and Beverage: $1,515 · Long Term Medical Supply Or Device Loan: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $4,983.08 |
| Food and Beverage | $1,514.95 |
| Long Term Medical Supply Or Device Loan | $910.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,585.68 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Integra Lifesciences Corporation | $1,022.04 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axonics, INC. | $446.94 | 2024 | Axonics, Bulkamid |
| Thd America, INC. | $348.09 | 2023-2025 | |
| Biom'Up Sa | $323.97 | 2019 | |
| Medtronic, INC. | $323.02 | 2023-2025 | Infinity Occipitocervical Upper Thoracic System, Interstim, Ligasure |
| Dilon Technologies, INC. | $308.61 | 2024-2025 | Hemoblast Bellows |
| Biom'Up France Sas | $179.18 | 2020 | |
| Prescient Surgical | $131.06 | 2019 | |
| Phathom Pharmaceuticals, INC. | $124.82 | 2025 | Voquezna |
| W. L. Gore & Associates, INC. | $100.00 | 2020 | |
| Exact Sciences Corporation | $59.65 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Daiichi Sankyo INC. | $42.16 | 2024 | Injectafer |
| Davol INC. | $33.39 | 2025 | Arista |
| Shield Therapeutics INC | $17.54 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.18 | 2023 | Gattex |
| Ethicon US, LLC | $14.68 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.56 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.